You just read:

Neuraltus Pharmaceuticals Announces Last Patient Out for Studies in ALS and Dyskinesias Associated with the Treatment of Parkinson's Disease

News provided by

Neuraltus Pharmaceuticals

Oct 04, 2010, 07:32 ET